Active

Xcellerant Ventures

Investor type

VC

Founded

2021

AUM

$26 M

Location

Scottsdale, Arizona, United States

Investment Ticket

$10-50 m

Investment Stage

Seed Pre-seed Series A

Region of investment

North America Europe

ESG Focus

Impact investor Women People of color and other minorities
Investor profile last updated: 26 September, 2026

Profile

Xcellerant Ventures is a venture capital firm based in Scottsdale, Arizona, founded in 2021 by John Shufeldt, Douglas Sylvester, and Chris Yoo. The firm specializes in healthcare investments, focusing on healthtech and medtech sectors. With a team of nine professionals, Xcellerant Ventures aims to empower entrepreneurs by providing hands-on advice and support, leveraging the founders' extensive experience in medical technologies, law, and entrepreneurship.

The firm primarily invests in early-stage companies that are developing innovative solutions to improve healthcare quality, efficiency, and accessibility. Xcellerant Ventures typically provides early-stage funding, with a focus on companies that have cleared regulatory hurdles and are on a rapid path to financial growth. The firm manages the Xcellerant Venture Capital Fund I, launched in 2023 with $7 million in assets under management, and the Jetstream Venture Fund, which targets high-growth technology and healthcare companies.

Notable investments by Xcellerant Ventures include Carbogenesis - industrial chemicals, Mindset Medical - healthcare technology systems, DeepLook Medical - decision/risk analysis, CRISPR QC - healthcare technology systems, and SimBioSys - decision/risk analysis.

Industry

HealthTech CleanTech Infrastructure Life Sciences MedTech AI Medical Devices Healthcare Services Biotechnology Aerospace

Xcellerant Ventures Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Xcellerant Venture Capital Fund I
Venture Capital (VC)
Biotechnology
Healthcare Services
MedTech
Life Sciences
Infrastructure
HealthTech
Pre-seed
Seed
North America
$5-10 m
$7 M
January 2023
Jetstream Venture Fund
Venture Capital (VC)
Aerospace
Biotechnology
MedTech
CleanTech
HealthTech
Seed
Europe
$1-5 m
—
March 2026

Contacts

Name
Title
Email
avatar
Chris Yoo General Partner & Managing Director
General Partner & Managing Director
c•••@•••
avatar
Yvette Ferreira Associate
Associate
y•••@•••
Upgrade to see contacts
avatar
Ytn75NkM4rL1AIV3 Ytn75NkM4rL1AIV3
Ytn75NkM4rL1AIV3
avatar
Ytn75NkM4rL1AIV3 Ytn75NkM4rL1AIV3
Ytn75NkM4rL1AIV3
avatar
Ytn75NkM4rL1AIV3 Ytn75NkM4rL1AIV3
Ytn75NkM4rL1AIV3
Investment-team contacts for Xcellerant Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Xcellerant Ventures

Xcellerant Ventures is a venture capital firm. It backs companies at Seed, Pre-seed and Series A, writing tickets of $10-50 m.
Xcellerant Ventures is located in Scottsdale, Arizona, United States.
Xcellerant Ventures was founded in 2021.
Xcellerant Ventures invests in companies and startups in HealthTech, CleanTech, Infrastructure, Life Sciences, MedTech, AI, Medical Devices, Healthcare Services, Biotechnology, Aerospace.
Xcellerant Ventures invests in companies and startups in North America, Europe.
Xcellerant Ventures invests in companies and startups at Seed, Pre-seed, Series A.
Xcellerant Ventures usually invests $10-50 m on average.
Xcellerant Ventures has around $26m assets under management.
Xcellerant Ventures last fund was created/launched in 2026-03-25
Xcellerant Ventures invests and supports Women, People of color and other minorities startups and founders.
Yes, Xcellerant Ventures is impact investor.
Xcellerant Ventures can be reached through its website xcellerantventures.com and its LinkedIn page. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Xcellerant Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Xcellerant Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 26 September, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.